The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year.

Jan 25, 2024 · Ranked: The Top 50 Pharmaceutical Giants. Together, the 50 biggest drugmakers make up a combined $4.7 trillion in market capitalization. With a market cap of over $578 billion, American pharmaceutical company Eli Lilly is the world’s most valuable, known for diabetes medications and its newly-launched weight-loss drug.

List of the largest pharma companies by market capitalization. Only the top publicly traded pharma companies are shown in this list. A pharmaceutical company is a company that is involved in the research, development or distribution of drugs and medication.

Apr 15, 2024 · At the top, Pfizer ceded the No. 1 slot as its revenue tumbled 41% from an industry record $100.3 billion in 2022 to $58.5 billion last year. The difference was directly attributable to...

Check out our roundup of 50 largest pharma companies and biotechs based on overall revenue figures pulled from annual reports.

Dec 7, 2024 · The US remains the top global pharma market, and is home to most of the top global pharma companies. In 2023, North America accounted for 53.3% of all global pharmaceutical sales, while Europe accounted for 22.7%.

Sep 10, 2024 · Here the Investing News Network provides an overview of the top 10 pharma companies by revenues, based on data compiled by Fierce Pharma. Read on to learn how they're driving the market...

Jan 21, 2025 · Explore the 100 largest pharmaceutical companies of 2024, featuring global leaders like Pfizer, AbbVie, Merck & Co., and more. ... Search. Search. Generics Bulletin. HBW Insight. In Vivo. Medtech Insight. Pink Sheet. Scrip. The World’s Top 100 Pharma Companies: 2024 Sales Rankings. 21 Jan 2025. Explore the 100 largest pharmaceutical companies ...

The below list of the top 10 biggest pharma companies in the world in 2024 is ranked by 2023 revenue for pharmaceutical sales only. 1. Pfizer - US$58.5bn. 2. Johnson & Johnson - US$54.76bn. 3. AbbVie - US$54.32bn. 4. Merck & Co - US$53.6bn. 5. Roche - US$49.9bn. 6. Sanofi - US$46.16bn. 7. AstraZeneca - US$45.8bn. 8. Novartis - US$45.4bn. 9.

Oct 7, 2024 · Based on 2023 drug revenue performance from global drug makers, the ranking reveals the effects of the end of the COVID-19 vaccine boom, the challenging patent cliffs certain Big Pharmas are coming up against, and the rewards of reaching blockbuster status. 1. Johnson & Johnson. 2022 position: 3. Rx Sales: USD 53.463 billion.